You are here: Home » Reuters » News
Business Standard

Takeda shareholders give nod for $59 billion Shire acquisition

Reuters  |  OSAKA 

By Takashi UmekawaOSAKA (Reuters) - Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt. Almost 90 percent of Takeda shareholders voted to approve the deal at an extraordinary general meeting held in Osaka, western Japan, the company said. Takeda will be joining the ranks of the world's top 10 drugmakers and gaining expertise in rare diseases through the deal, the biggest overseas acquisition by a Japanese company.It will also become one ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Wed, December 05 2018. 09:39 IST